Reprogramming Immunosuppressive Niches and the Cancer Immunity Cycle in Pancreatic Cancer with Neoantigen mRNA Plus Immune Adjuvant Nanocarrier Strategies

By afschroeder • November 23, 2025

Nel AE, Luo L, Liao YP, Wang X. Reprogramming Immunosuppressive Niches and the Cancer Immunity Cycle in Pancreatic Cancer with Neoantigen mRNA Plus Immune Adjuvant Nanocarrier Strategies. ACS Nano. 2025 Nov 22. doi: 10.1021/acsnano.5c14753. Epub ahead of print. PMID: 41273281.

Tags: General Internal Medicine, immune adjuvant nanocarrier, immune tolerance, immunotherapy, lipid nanoparticle, mRNA, Nano Medicine, Pancreatic ductal adenocarcinoma (PDAC), Post Doc, Publications, reprogramming, tumor microenvironment

Vocal Outcomes After Cell-Based Outer Vocal Fold Implant in Porcine Bilateral Vocal Fold Resection

Zhang K, Crane G, Alvarez MR, Klomhaus A, Alhiyari Y, Gowda B, Döllinger M, Long J. Vocal Outcomes After Cell-Based Outer Vocal Fold Implant in[...]

The Exam Room as Sanctuary – Caring for Undocumented Patients

Linares MA, Liauw D, Cervantes L. The Exam Room as Sanctuary - Caring for Undocumented Patients. N Engl J Med. 2026 Jul 11. doi: 10.1056/NEJMp2603126.[...]

Cardiovascular outcomes of empagliflozin-GLP-1RA combination therapy in type 2 diabetes: EMPRISE study

Htoo PT, Cho H, Paik JM, Bykov K, Everett BM, Glynn RJ, Shay C, Schmedt N, Wexler DJ, Patorno E. Cardiovascular outcomes of empagliflozin-GLP-1RA combination[...]